Physician profile
Sami Tuffaha
NPI 1922398866
$16,426.26
in general payments reported to CMS, 2019-2025
15 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,221 · 2020: $641 · 2021: $2,757 · 2022: $4,911 · 2023: $4,245 · 2024: $282 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,775 · Food and Beverage: $1,025 · Education: $96.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,775.00 |
| Food and Beverage | $1,025.03 |
| Education | $96.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $6,659.25 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Checkpoint Surgical, INC | $5,445.56 | 2021-2025 | Checkpoint Stimulators |
| Arthrex, INC. | $2,407.61 | 2019 | |
| Supreme Orthopedic Systems, LLC | $561.73 | 2020 | |
| Gemini Medical LLC | $412.48 | 2019 | |
| Trimed, INC. | $193.61 | 2023 | |
| Allergan, INC. | $142.94 | 2022 | |
| Abbvie INC. | $135.47 | 2023 | Alloderm |
| Endo Pharmaceuticals INC. | $118.19 | 2021 | |
| Mentor Worldwide LLC | $109.09 | 2022 | |
| Biocircuit Technologies INC | $84.17 | 2025 | Nerve Tape |
| Depuy Synthes Sales INC. | $56.71 | 2020 | |
| Spr Therapeutics, INC | $53.34 | 2019 | |
| Stryker Corporation | $46.11 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sami Tuffaha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.